조혈모세포 이식 환자의 불면증

키워드

참고문헌 (95)

1. 김병국, "종양학", pp.983~991 (2003), 일조각
2. Niederwieser D, "Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the worldwide network for blood and marrow transplantation group including the global survey", Bone Marrow Transplant, 51, pp.778~785 (2016)
3. Majhail NS, "Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation", Biol Blood Marrow Transplant, 21, pp.1863~1869 (2015)
4. "소개 및 현황" (2018), 대한적십자사혈액관리본부[URL]
5. 박상은, "조혈모세포이식 환자의 무균실 입원 중 수면에관한 서술적 질적 연구", 석사, pp.2016
6. Okamoto S, "Current indication for hematopoietic cell transplantation in adults", Hematol Oncol Stem Cell Ther, 10, pp.178~183 (2017)
7. Jim HSL, "Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management", Biol Blood Marrow Transplant, 20, pp.1465~1484 (2014)
8. Jim HS, "Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation", Cancer, 122, pp.1290~1297 (2016)
9. Cheung YT, "Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia", Cancer, 123, pp.3410~3419 (2017)
10. Wu HS, "Fatigue and disrupted sleep-wake patterns in patients with cancer: a shared mechanism", Clin J Oncol Nurs, 16, pp.E56~E68 (2012)
11. Ghazikhanian SE, "Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue", Bone Marrow Transplant, 52, pp.279~284 (2017)
12. Nelson AM, "Sleep quality following hematopoietic stem cell transplantation: longitudinal trajectories and biobehavioral correlates", Bone Marrow Transplant, 49, pp.1405~1411 (2014)
13. 최소은, "조혈모세포 이식환자의 입원 후 수면의 질과 수면양상의 변화", Journal of Hospice and Palliative Care, 8(1), pp.37~44 (2005), 한국호스피스완화의료학회
14. Sayadi L, "Views of patients undergo hematopoietic stem cell transplantation on their basic needs", Int J Hematol Oncol Stem Cell Res, 7, pp.23~29 (2013)
15. Savard J, "Insomnia in the context of cancer:a review of a neglected problem", J Clin Oncol, 19, pp.895~908 (2001)
16. Howell D, "Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice", Ann Oncol, 25, pp.791~800 (2014)
17. Morin CM, "Insomnia: psychological assessment and management", pp.3~6 (1993), Guilford Press
18. American Psychiatric Association, "정신질환의 진단및 통계편람", pp.392~394 (2015), 학지사
19. Coleman EA, "Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma", Cancer Nurs, 34, pp.219~227 (2011)
20. D’Souza A, "Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation", Bone Marrow Transplant, 53, pp.1079~1082 (2018)
21. Lee MS, "Coping, stress, and insomnia in hematopoietic stem cell transplant candidates", Psychooncology, 26, pp.560~562 (2017)
22. Sohn SI, "The reliability and validity of the korean version of the pittsburgh sleep quality index", Sleep Breath, 16, pp.803~812 (2012)
23. Enderlin CA, "Sleep measured by polysomnography in patients receiving high-dose chemotherapy for multiple myeloma prior to stem cell transplantation", Oncol Nurs Forum, 40, pp.73~81 (2013)
24. Savard J, "Natural course of insomnia comorbid with cancer:an 18-month longitudinal study", J Clin Oncol, 29, pp.3580~3586 (2011)
25. Fann JR, "Psycho-oncology", pp.144~154 (2015), Oxford University Press
26. Rischer J, "Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation", Bone Marrow Transplant, 44, pp.121~128 (2009)
27. Bevans MF, "The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation(HSCT)", Support Care Cancer, 16, pp.1243~1254 (2008)
28. Anderson KO, "Symptom burden in patients undergoing autologous stem-cell transplantation", Bone Marrow Transplant, 39, pp.759~766 (2007)
29. Cohen MZ, "Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation", J Pain Symptom Manage, 44, pp.168~180 (2012)
30. Kim R, "Temporal trajectory of quality of life and its predictors in recipients of hematopoietic stem cell transplantation", Ann Hematol, 97, pp.1407~1415 (2018)
31. Boonstra L, "Sleep disturbance in hospitalized recipients of stem cell transplantation", Clin J Oncol Nurs, 15, pp.271~276 (2011)
32. Savard J, "Insomnia and cancer: prevalence, nature, and nonpharmacologic treatment", Sleep Med Clin, 8, pp.373~387 (2013)
33. Lowery AE, "Psycho-oncology", pp.231~238 (2015), Oxford University Press
34. Nelson AM, "Sleep disruption among cancer patients following autologous hematopoietic cell transplantation", Bone Marrow Transplant, 53, pp.307~314 (2018)
35. Faulhaber GA, "Association of busulfan and cyclophosphamide conditioning with sleep disorders after hematopoietic stem cell transplantation", Acta Haematol, 124, pp.125~128 (2010)
36. Jim HSL, "Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation:a secondary data analysis from the BMT CTN 0902 trial", Bone Marrow Transplant, 53, pp.1038~1043 (2018)
37. Pidala J, "Quality of life after allogeneic hematopoietic cell transplantation", Blood, 114, pp.7~19 (2009)
38. Applebaum AJ, "A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions", Bone Marrow Transplant, 51, pp.1416~1422 (2016)
39. Hjermstad M, "A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation", Bone Marrow Transplant, 34, pp.257~266 (2004)
40. Diez-Campelo M, "Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study", Bone Marrow Transplant, 34, pp.729~738 (2004)
41. Bevans M, "Health-related quality of life following allogeneic hematopoietic stem cell transplantation", Hematology Am Soc Hematol Educ Program, 2010, pp.248~254 (2010)
42. Boyes AW, "Prevalence and correlates of the unmet supportive care needs of individuals diagnosed with a haematological malignancy", Acta Oncol, 54, pp.507~514 (2015)
43. Miller AH, "Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer", J Clin Oncol, 26, pp.971~982 (2008)
44. Savard J, "Chronic insomnia and immune functioning", Psychosom Med, 65, pp.211~221 (2003)
45. Savard J, "Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects", J Clin Oncol, 23, pp.6097~6106 (2005)
46. Spielman AJ, "Case studies in insomnia", pp.1~15 (1991), Springer Science & Business Media
47. Matthews EE, "Sleep disturbances in acutely ill patients with cancer", Crit Care Nurs Clin North Am, 28, pp.253~268 (2016)
48. Andrykowski M, "Energy level and sleep quality following bone marrow transplantation", Bone Marrow Transplant, 20, pp.669~679 (1997)
49. Heinonen H, "Gender-associated differences in the quality of life after allogeneic BMT", Bone Marrow Transplant, 28, pp.503~509 (2001)
50. Watson M, "Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK medical research council AML 10 trial", Eur J Cancer, 40, pp.971~978 (2004)
51. Sherman AC, "Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation", 11, pp.568~574 (2003)
52. Wagner LI, "Fatigue and cancer: causes, prevalence and treatment approaches", Br J Cancer, 91, pp.822~828 (2004)
53. Barata A, "Unmet needs for psychosocial care in hematologic malignancies and hematopoietic cell transplant", Curr Hematol Malig Rep, 11, pp.280~287 (2016)
54. Ram R, "Prophylaxis regimens for GVHD: systematic review and meta-analysis", Bone Marrow Transplant, 43, pp.643~653 (2009)
55. El-Jawahri A, "Impact of psychological distress on quality of life, functional status, and survival in patients with chronic graft-versus-host disease", Biol Blood Marrow Transplant (2018)
56. Allen RP, "MRI measurement of brain iron in patients with restless legs syndrome", Neurology, 56, pp.263~265 (2001)
57. Savard J, "Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study", Cancer, 121, pp.1703~1711 (2015)
58. Hjorth M, "Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study", Eur J Haematol, 88, pp.485~496 (2012)
59. Harder H, "Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation", Cancer, 95, pp.183~192 (2002)
60. Moser NJ, "Effects of dexamethasone on sleep", Pharmacol Toxicol, 79, pp.100~102 (1996)
61. Rosen G, "The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia", Sleep Med, 16, pp.503~509 (2015)
62. Rodin G, "Traumatic stress in patients with acute leukemia: a prospective cohort study", Psychooncology, 27, pp.515~523 (2018)
63. 윤수정, "스트레스 대처방식이 조혈모세포 이식 환자의 우울과 불안에 미치는 영향", 정신신체의학, 10(1), pp.8~17 (2002), 한국정신신체의학회
64. Fife BL, "Longitudinal study of adaptation to the stress of bone marrow transplantation", J Clin Oncol, 18, pp.1539~1549 (2000)
65. Glanz K, "Health behavior and health education : theory, research, and practice", pp.211~236 (2008), John Wiley & Sons
66. Simard S, "Fear of cancer recurrence:specific profiles and nature of intrusive thoughts", J Cancer Survivorship, 4, pp.361~371 (2010)
67. Gabor JY, "Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects", Am J Respir Crit Care Med, 167, pp.708~715 (2003)
68. Hacker ED, "Sleep interrupted:nocturnal care disturbances following hematopoietic stem cell transplantation", Clin J Oncol Nurs, 17, pp.517~523 (2013)
69. Arrendale KK, "Improving sleep quality of BMT patients during the inpatient stay", Biol Blood Marrow Transplant, 23, pp.S468~S469 (2017)
70. Kunitomi A, "Insomnia and depression during protective isolation in patients with hematological disorders", Intern Med, 49, pp.17~22 (2010)
71. Diamond C, "Patient experience of admission to critical care unit(CCU) during haematopoietic stem cell transplant(HSCT); and clinical research portfolio", doctorate, pp.2013
72. Perlis ML, "Cognitive behavioral treatment of insomnia: a session-bysession guide", pp.1~104 (2006), Springer Science & Business Media
73. National Institutes of Health, "National institutes of health state of the science conference statement on manifestations and management of chronic insomnia in adults, june 13-15, 2005", Sleep, 28, pp.1049~1057 (2005)
74. Savard J, "Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects", J Clin Oncol, 23, pp.6083~6096 (2005)
75. Ancoli-Israel S, "Sleep disturbances in cancer: a review", Sleep Med Res, 6, pp.45~49 (2015)
76. Ancoli-Israel S, "Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer", Support Care Cancer, 20, pp.1211~1219 (2012)
77. Neikrug AB, "Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer", Behav Sleep Med, 10, pp.202~216 (2012)
78. Miguel C, "Drug interaction in psychooncology:antidepressants and antineoplastics", Pharmacology, 88, pp.333~339 (2011)
79. Savard J, "Principles and practice of sleep medicine", pp.1286~1299 (2017), Elsevier
80. Dimsdale JE, "Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies", Support Care Cancer, 19, pp.2015~2020 (2011)
81. Poon A LL, "Thomas’ hematopoietic cell transplantation: stem cell transplantation", pp.1206~1217 (2016), John Wiley & Sons
82. Brüggemann RJ, "Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents", Clin Infect Dis, 48, pp.1441~1458 (2009)
83. Saari TI, "Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects", Br J Clin Pharmacol, 63, pp.116~120 (2007)
84. Greenblatt DJ, "Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole", Clin Pharmacol Ther, 64, pp.661~671 (1998)
85. Saari TI, "Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam", Clin Pharmacol Ther, 79, pp.362~370 (2006)
86. Varhe A, "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole", Clin Pharmacol Ther, 56, pp.601~607 (1994)
87. Fernández de Palencia Espinosa, "Potential drug–drug interactions in hospitalised haematological patients", J Oncol Pharm Pract, 23, pp.443~453 (2017)
88. Guastaldi RBF, "Prevalence of potential drug–drug interactions in bone marrow transplant patients", Int J Clin Pharm, 33, pp.1002~1009 (2011)
89. Li M, "Evidence-based treatment of depression in patients with cancer", J Clin Oncol, 30, pp.1187~1196 (2012)
90. Manitpisitkul W, "Drug interactions in transplant patients: what everyone should know", Curr Opin Nephrol Hypertens, 18, pp.404~411 (2009)
91. Talib WH, "Melatonin and cancer hallmarks", Molecules, 23, pp.E518~ (2018)
92. Seely D, "Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials", Integr Cancer Ther, 11, pp.293~303 (2012)
93. Zhelev Z, "Synergistic cytotoxicity of melatonin and new-generation anticancer drugs against leukemia lymphocytes but not normal lymphocytes", Anticancer Res, 37, pp.149~159 (2017)
94. "Sleep disorders-health professional version" (2018)[URL]
95. "NCCN guidelines for supportive care" (2018)[URL]

관련 논문AI추천